Headlands Technologies LLC Makes New Investment in Repligen Co. (NASDAQ:RGEN)
Headlands Technologies LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 474 shares of the biotechnology company’s stock, valued at approximately $75,000. Several other institutional investors have also recently added to […]